GlassScriptPhysician profile
Ryan Machiele
NPI 1821610189
$2,048.45
in general payments reported to CMS, 2019-2025
15 companies · $1,239 in 2025
The $1,239 reported for 2025 was more than what 82% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $123 · 2024: $686 · 2025: $1,239.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,048.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,048.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $524.95 | 2023-2025 | Clareon Panoptix Pro, Hydrus Microstent, Centurion |
| Biotissue Holdings INC. | $393.13 | 2024-2025 | |
| Johnson & Johnson Surgical Vision, INC. | $356.66 | 2024-2025 | Tecnis Simplicity, Tecnis Iol, Catalys System |
| Ocular Therapeutix, INC. | $196.59 | 2024-2025 | Dextenza |
| Amgen INC. | $150.49 | 2025 | Tepezza |
| Mallinckrodt Hospital Products INC. | $99.18 | 2024-2025 | Acthar |
| Tarsus Pharmaceuticals, INC. | $71.94 | 2024-2025 | Xdemvy |
| Abbvie INC. | $48.76 | 2025 | |
| Harrow Eye, LLC | $39.42 | 2025 | Vevye |
| Bausch & Lomb Americas INC. | $35.17 | 2025 | Vyzulta, Totalvisc |
| Dompe US, INC. | $33.39 | 2024 | Oxervate |
| Rayner Intraocular Lenses Limited | $31.87 | 2024 | Rayner Cataract Set 1, Rayone Spheric, Rayone Aspheric |
| Thea Pharma INC. | $31.44 | 2024 | Iyuzeh |
| Ani Pharmaceuticals, INC. | $19.05 | 2024 | Purified Cortrophin Gel |
| Rxsight INC | $16.41 | 2025 | Rxsight Injector Cartridge, Rxsight Contact Lens, Light Adjustable Lens (Lal) |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Machiele listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.